Paradigm shift in neuroprotective drug development: clinically tolerated NMDA receptor inhibition by memantine
Lipton S, Chen H. Paradigm shift in neuroprotective drug development: clinically tolerated NMDA receptor inhibition by memantine. Cell Death & Differentiation 2003, 11: 18-20. PMID: 14647237, DOI: 10.1038/sj.cdd.4401344.Peer-Reviewed Original Research